Skip to main content

iwCLL 2023 Main banner

iwCLL X / Twitter

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Title

Browse by Poster Title

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#

P
1150
Past informs the future: outcomes post allogeneic stem cell transplantation in high risk chronic lymphocytic leukaemia (CLL)
Past, Present, and Future in CLL

Favorite
1144
Patients with unmutated IgHV_1-69; 1-02; 3-30; 4-39 and high expression of AID enzyme need earlier treatment.
Pathogenesis of CLL

Favorite
1131
Performance of a novel 8-color flow cytometry panel in the detection of minimal residual disease assessment of chronic lymphocytic leukemia
Clinical Challenges in CLL

Favorite
1113
Pericardial effusion in patients with chronic lymphocytic leukemia treated with Bruton's tyrosine kinase inhibitors
Therapy of CLL

Favorite
1028
Peripheral Blood CXCR4hiCD5hi Chronic Lymphocytic Leukaemia Cells are Primed for Returning to the Lymph Nodes for further Activation and Proliferation
Pathogenesis of CLL

Favorite
1114
Pharmacokinetics of idelalisib and outcomes
Therapy of CLL

Favorite
2024
Phase 1/2 Study of Zilovertamab and Ibrutinib: Durable responses suggest a novel mechanism for synthetic lethality in TP53 aberrant disease.
Clinical Challenges in CLL

Favorite
1052
PI3K inhibitor-resistant B-cell lymphomas show distinct functional phenotypes characterized by sensitivity to Bcl-2- or proteasome-inhibition
Clinical Challenges in CLL

Favorite
1135
Predictive modeling of treatment outcomes in chronic lymphocytic leukemia based on functional profiles at baseline
Clinical Challenges in CLL

Favorite
1140
Pregnancy course of 10 women diagnosed with Chronic Lymphocytic Leukemia
Clinical Challenges in CLL

Favorite
1047
Prognosis Analysis and Validation of Fatty Acid Metabolism-Related Signature in Chronic lymphocytic leukemia
Pathogenesis of CLL

Favorite
2022
Prolonged treatment with ibrutinib modulates phenotypic and functional features of immune cell compartments in chronic lymphocytic leukemia
Therapy of CLL

Favorite